Maven Securities »

Amylyx Pharmaceuticals shares owned by Maven Securities

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Maven Securities from 13F filings

Historical chart of Maven Securities investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by Maven Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by Maven Securities

Quarter filed Position value Share count Share price at filing
2024-06-30 $190k 100k 1.90
2024-03-31 $71k 25k 2.84
2023-03-31 $2.9M 100k 29.34
2022-12-31 $5.5M 150k 36.95

More positions owned by Maven Securities

Spdr S&p 500 Etf Tr Call Call Option
United States Stl Corp Put Put Option
Spdr S&p 500 Etf Tr Put Put Option
Vaneck Etf Trust Put Put Option
United States Stl Corp Call Call Option
Select Sector Spdr Tr Put Put Option
Invesco Qqq Tr Put Put Option
Capri Holdings Call Call Option
Capri Holdings Put Put Option
Select Sector Spdr Tr Put Put Option
Select Sector Spdr Tr Put Put Option
Ishares Tr Call Call Option
Select Sector Spdr Tr Call Call Option
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr Call Call Option

View all positions for Maven Securities

Top funds holding Amylyx Pharmaceuticals

Vanguard Group
BlackRock
Goldman Sachs Group
BlackRock
Citadel Advisors
Perceptive Advisors
Alyeska Investment Group
683 Capital Management
Almitas Capital
Standard Life Aberdeen
Acadian Asset Management
Nantahala Capital Management
Two Sigma Investments
Two Sigma Advisers
Farallon Capital Management

View all funds holding Amylyx Pharmaceuticals